RAPT Therapeutics (RAPT) Profit After Tax (2020 - 2023)
Historic Profit After Tax for Therapeutics (RAPT) over the last 4 years, with Q4 2023 value amounting to -$30.9 million.
- Therapeutics' Profit After Tax fell 3453.88% to -$30.9 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$116.8 million, marking a year-over-year decrease of 3931.63%. This contributed to the annual value of -$116.8 million for FY2023, which is 3931.63% down from last year.
- Therapeutics' Profit After Tax amounted to -$30.9 million in Q4 2023, which was down 3453.88% from -$31.4 million recorded in Q3 2023.
- Therapeutics' 5-year Profit After Tax high stood at -$12.4 million for Q2 2020, and its period low was -$31.4 million during Q3 2023.
- Over the past 4 years, Therapeutics' median Profit After Tax value was -$18.9 million (recorded in 2021), while the average stood at -$20.2 million.
- Its Profit After Tax has fluctuated over the past 5 years, first crashed by 1385.45% in 2022, then crashed by 4773.25% in 2023.
- Over the past 4 years, Therapeutics' Profit After Tax (Quarter) stood at -$12.7 million in 2020, then crashed by 40.79% to -$17.9 million in 2021, then fell by 28.01% to -$23.0 million in 2022, then plummeted by 34.54% to -$30.9 million in 2023.
- Its last three reported values are -$30.9 million in Q4 2023, -$31.4 million for Q3 2023, and -$25.3 million during Q2 2023.